The first genome-wide association study identifying new susceptibility loci for obstetric antiphospholipid syndrome
The first genome-wide association study identifying new susceptibility loci for obstetric antiphospholipid syndrome
复制标题
第一项全基因组关联研究确定了产科抗磷脂综合征的新易感位点
DOI:
10.1038/jhg.2017.46
复制
发表时间:
2017
影响因子:
3.5
通讯作者:
Ozaki Ya
中科院分区:
文献类型:
--
作者:
Sugiura-Ogasawara Mayumi;Omae Yosuke;Kawashima Minae;Toyo-Oka Licht;Khor Seik-Soon;Sawai Hiromi;Horita Tetsuya;Atsumi Tatsuya;Murashima Atsuko;Fujita Daisuke;Fujita Tomio;Morimoto Shinji;Morishita Eriko;Katsuragi Shinji;Kitaori Tamao;Katano Kinue;Ozaki Ya
Antiphospholipid syndrome (APS) is the most important treatable cause of recurrent pregnancy loss. The live birth rate is limited to only 70–80% in patients with APS undergoing established anticoagulant therapy. Lupus anticoagulant (LA), but not anticardiolipin antibody (aCL), was found to predict adverse pregnancy outcome. Recent genome-wide association studies (GWAS) of APS focusing on aCL have shown that several molecules may be involved. This is the first GWAS for obstetric APS focusing on LA. A GWAS was performed to compare 115 Japanese patients with obstetric APS, diagnosed according to criteria of the International Congress on APS, and 419 healthy individuals. Allele or genotype frequencies were compared in a total of 426 344 single-nucleotide polymorphisms (SNPs). Imputation analyses were also performed for the candidate regions detected by the GWAS. One SNP (rs2288493) located on the 3′-UTR of TSHR showed an experiment-wide significant APS association (P= 7.85 E-08, OR= 6.18) under a recessive model after Bonferroni correction considering the number of analyzed SNPs. Another SNP (rs79154414) located around the C1D showed a genome-wide significant APS association (P= 4.84 E-08, OR= 6.20) under an allelic model after applying the SNP imputation. Our findings demonstrate that a specific genotype of TSHR and C1D genes can be a risk factor for obstetric APS.